Physicians who were alerted about scarce supplies ordered 29 percent fewer blood clotting tests, according to a study published July 18 in Jama Internal Medicine. The reduced level of tests ordered lasted for months after the shortage alerts were initially introduced.
Previous studies have suggested that as much as 90 percent of some tests with the blue top tubes are not clinically indicated, the study said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
